All News

knee.surg2_.jpg (keep)

Updated ACR/AAHKS Guidelines on Drug Use in Knee & Hip Arthroplasty Patients

d ACR

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Read Article
Vaccination,vaccine

Downside of Holding Methotrexate with COVID-19 Vaccination

d Jack Cush, MD

A recent prospective, randomized, blinded clinical trial has shown that a 2 week hold of methotrexate (MTX) following COVID-19 (Sinovac-CoronaVac) vaccination resulted in greater anti-SARS-CoV-2 immunogenicity; but there was an increase in flare rates after the second dose of vaccine.

Read Article
COVID,nasal,PCR,test,swab

MMWR - NFL Study on When to Be Released if COVID(+)

d Jack Cush, MD

MMWR has reported the results of the National Football Leagues (NFL) change in SARS-CoV-2 testing program that went into effect in December 2021, at the height of the Omicron variant surge, showing that among those with asymptomatic infection, only half were PCR test negative and could return to

Read Article
RheumNow Podcast square

Diagnostic Delay in Axial Spondyloarthritis (2.25.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live.

Read Article
Acute onset swelling in but a few joints. What's a hairdresser to do? What would you do? QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas) https://t.co/KYI05R1h5J https://t.co/GobpZ4TRhQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Listen in… Fellow Case Presentations From RWCS 2022 https://t.co/SvaGfyDDTK https://t.co/MP9iWQK8ZB

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live. Download wherever you get your podcasts. https://t.co/AR08F92XSY https://t.co/sqqlHvSHUL

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Prevent NSAID GI bleeding or perforation? Korean study (n=92K) shows (vs non-prophylaxis) PPI and COX-2 inhibitors associated with 64% and 74% reduced risk. COX2 = PPI +nsNSAID. H2-receptor antag. did not reduce the risk https://t.co/pUuVzwiQgx https://t.co/JAUqW9AMck

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: 144 SLE pts from the SLICC cohort were studied showing that a majority (61.2%) scores consistent with depression over 4 yrs; also an inconsistent association between disease activity and depression in multivariate analysis https://t.co/YqxPFtYohf

Links:

Dr. John Cush RheumNow ( View Tweet)

ICYMI: Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/GvyXzcSNUa https://t.co/T83m5YojcH

Links:

Dr. John Cush RheumNow ( View Tweet)
In case you missed it… RA: Still a Clinical Diagnosis https://t.co/8RrhxAgbkP https://t.co/R9EpxSE9Gr

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Positive Results from the DOA (Duloxetine in OsteoArthritis) Study https://t.co/JU0OeQgmta https://t.co/IRv3C747Zt

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast available for download! Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live. https://t.co/jQAq6iBvca https://t.co/FgIG1ogPGo

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to share that Kaleb Michaud, PhD, will be presenting on Adherence to Rheumatoid Therapies during our RA-Future Improvement Pod at RheumNow Live on 3/19. Have you registered yet? https://t.co/HOOMh84MF0 https://t.co/5lPijPoN9b

Links:

Dr. John Cush RheumNow ( View Tweet)
MMWR - NFL Study on When to Be Released if COVID(+) MMWR has reported the results of the National Football Leagues (NFL) change in SARS-CoV-2 testing program that went into effect in December 2021. https://t.co/EoIjc0XL0R https://t.co/ysRPao1oC2

Links:

Dr. John Cush RheumNow ( View Tweet)
COSMOS Study - Guselkumab Efficacy at 1 Year in Psoriatic Arthritis https://t.co/kl6RzE6hK2 https://t.co/vLY2xQAqwn

Links:

Dr. John Cush RheumNow ( View Tweet)
FDA granted Breakthrough Therapy Designation Boehringer Ingelheims BI 1015550 - a oral, phosphodiesterase 4B inhibitor (antifibrotic & anti-inflammatory), now in phase II trials for idiopathic pulmonary fibrosis https://t.co/SMXEweSVAR

Links:

Dr. John Cush RheumNow ( View Tweet)

SLE mortality rates (ASMR) nearly doubled since 1998 & remain high (vs non-SLE mortality) w/ significant sex & regional disparities. Data from 11449 SLE deaths, ASMR signif increased 1998 to 2009, down 2009 to 2013 and increased thereafter https://t.co/kSc3Cn2Bl5

Links:

Dr. John Cush RheumNow ( View Tweet)

Diagnostic delay in axial spondyloarthritis? Systematic review shows Dx delay ranged 0.67 to 8 years (>75% =,2-6 yrs). Only 1/3 had median delay ~ 2 yrs. Gender and +FamHx did not influence Dx Delay. https://t.co/R5WwCvZPzc

Links:

Dr. John Cush RheumNow ( View Tweet)

Where you live doesn't alter your risk for RA. Systematic review of 54 articles, 11 studies shows that rural/remote populations had no greater #RA risk. But Rural/remote pts have >barriers to care which increases the risk for inequities in outcomes. https://t.co/8fhFSQ54rt https://t.co/qJhNFcb0b2

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×